Dexmedetomidine for Sedation of Neonates with HIE Undergoing Therapeutic Hypothermia: A Single-Center Experience

Dexmedetomidine for Sedation of Neonates with HIE Undergoing Therapeutic Hypothermia: A Single-Center Experience

Hypoxic-ischemic encephalopathy (HIE) is a significant cause of morbidity and mortality in neonates. Therapeutic hypothermia reduces the risk of death or disability. Providing optimal sedation while neonates are undergoing therapeutic hypothermia is likely beneficial but may present therapeutic chal...

Full description

Bibliographic Details
Main Authors: Keliana O'Mara, Michael D. Weiss
Format: Article
Language:English
Published: Thieme Medical Publishers, Inc. 2018-07-01
Series:American Journal of Perinatology Reports
Subjects:
hypoxic-ischemic encephalopathy
sedation
dexmedetomidine
neonate
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1669938

Similar Items

Similar Items